pacb stock price target

Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Fundamental company data provided by Morningstar and Zacks Investment Research. Friday, January 03, … 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. large volume large price increase and initial breakout price target 20-25% higher from current price. The average price target represents a -36.68% upside from the last price of $9.87. Identify stocks that meet your criteria using seven unique stock screeners. You can opt out at any time. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . Target Median Price ... price target to $15 … (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. Learn about financial terms, types of investments, trading strategies and more. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. Based on analysts offering 12 month price targets for PACB in the last 3 months. 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. Get daily stock ideas top-performing Wall Street analysts. Export data to Excel for your own analysis. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. 4 Wall Street analysts have issued 1-year price objectives for Pacific Biosciences of California's stock. The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target to $1.. MT. Our Chief Technology Analyst recently found himself in a room with billionaire Elon Musk... MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Shares of PACB stock opened at $36.93 on Monday. He realized he could follow along - and take a slice of the profit. Pacific Biosciences of California (NASDAQ:PACB) had its target price lifted by Piper Sandler from $12.00 to $20.00 in a research note published on … The extremes of the forecast give a target low and a target high … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5 MarketWatch. Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. The high price target for PACB is $45.00 and the low price target for PACB is $12.00. The stocks of PACB opened up on Tuesday, trading at $22.32. Below are some Prices are above the rising 40-week moving average line with a bullish OBV line and MACD oscillator. Coronavirus update: At least 724 deaths, WHO to send mission, American dies in China MarketWatch. PACB updated stock price target summary. Receive a free world-class investing education from MarketBeat. The simple moving average over 50-days has been set at $15.15, while the simple moving average over 200-days is $8.25. S&P 500, 10 ETFs With Stocks That document.write(''); View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. View which stocks are hot on social media with MarketBeat's trending stocks report. The brokerage currently has a neutral rating on the biotechnology company’s stock… The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Pacific Biosciences Of California Inc's upside potential (average analyst target price relative to current price) is greater than 1.75% of all US stocks. PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. Crossing Above Their 200 Day Moving Avg, 10 Canadian Stocks ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. The 12-month stock price forecast is 24.25, which is a decrease of -37.15% from the latest price. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, MicroStrategy (NASDAQ:MSTR) Slips on Troubles in Bitcoin. The consensus price target of analysts on Wall Street is $27.8, which implies a decline of -23.44% to the stock’s current value. The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -33.71% from its recent market value. This is 2.11% less than the trading day before Thursday, 14th Jan 2021. JP Morgan, on the other hand, stated in their research note that they expect to see PACB reach a price target of $15. ETF as far as deciding whether to continue to hold the stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Looking for new stock ideas? “...Where I Uncovered The Market’s Next $260 Billion Growth Story” Their average twelve-month price target is $23.00, predicting that the stock has a possible downside of 38.54%. Learn everything you need to know about successful options trading with this three-part video course. 06:54 PM ET. The average price target is $6.25, with a high forecast of $7.00 and a … 4 Wall Street analysts have issued ratings and price targets for Pacific Biosciences of California in the last 12 months. The average price target is $16.33 with a high forecast of $25.00 and a low forecast of $12.00. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Crossing Above Their 200 Day Moving Average, 10 Stocks PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Get the latest Zacks research report on PACB — FREE. “I Was Recently In A Private Meeting With Billionaire Elon Musk...". Learn more. During the day the stock fluctuated 11.15% from a day low at $36.68 to a day high of $40.77. The technical evaluation for the stock shows the PEG ratio is 0, with PACB’s current price about 28.4% and 47.99% off the 20-day and 50-day simple moving averages respectively. Target Median Price Webull offers PacBio (PACB) historical stock prices, in-depth market analysis, NASDAQ: PACB real-time stock quote data, in-depth charts, and a fully built financial calendar to help you invest smart. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PACB stock is a recommendation set at 2.60. S&P 500, Forgotten S&P 500 Giants: Based on 1 analyst offering 12 month price targets for Lantheus in the last 3 months. According to 5 analysts, the average rating for PACB stock is "Buy." Price Target As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock. Want to see which stocks are moving? See what's happening in the market right now with MarketBeat's real-time news feed. Lantheus Holdings Stock Price Forecast, LNTH stock price prediction. I own this stock after holding support at the 10day moving average. The high price target for PACB is $25.00 … Pacific Biosciences of California, Inc. Common Stock (PACB) Nasdaq ... PACB PACB AFTER HOURS QUOTE PACB LATEST AFTER ... You'll now be able to see real-time price and activity for … This is 2.11% less than the trading day before Thursday, 14th Jan 2021. Stocks Increasing Payments For Decades, Broker Darlings: Top 15 Analyst Picks Saturday, February 08, 2020. stock remains in the index, it doesn't much matter whether analysts find the stock overvalued or undervalued. Based on 3 analysts offering 12 month price targets for Pacific Biosciences in the last 3 months. $7.99 Stop Loss. Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: … 79% of all stocks covered), data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on PACB — FREE, 10 ETFs With Most Upside The predicted price for PACB in the upcoming period, according to Piper Sandler is $12 based on the research report published on November 03rd of the previous year 2020. High-Yield Canadian Energy Stocks, 10 Canadian Stocks Crossing PACB updated stock price target summary. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. PACB -- USA Stock : USD 36.92 3.28 8.16% : ... Pacific analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models. Piper Jaffray gave “ Overweight” rating to PACB stocks, setting the target price at $8 in the report published on October 15, 2019. These price ends are -55.77% and -7.85% off the current price level respectively, although investors could be excited at the prospect of a -44.71% if the PACB share price touches on the median price of $15. (Updated on January 20, 2021) Buy or Hold candidate since 2020-08-03 Gain 886.83% PDF . Crossing Below Their 200 Day Moving Average, 10 Canadian Stocks Where (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Pacific Biosciences of … There’s one other MAJOR way Biden’s new plan will affect you and your money. The brokerage currently has a neutral rating on the biotechnology company’s stock. All rights reserved. The business’s fifty day moving average is $24.69 and its 200 day moving average is $12.75. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. Get short term trading ideas from the MarketBeat Idea Engine. Pacific Biosciences of California (NASDAQ:PACB) had its price target hoisted by Piper Sandler from $12.00 to $20.00 in a research report sent to investors on Friday morning, The Fly reports. According to 5 analysts, the average rating for PACB stock is "Buy." The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Pacific Biosciences of California Inc (PACB) stock is trading at $28.22 as of 2:50 PM on Wednesday, Dec 23, a rise of $1.27, or 4.71% from the previous closing price of $26.95. Andrew Keene was "down and out"... until he found an obscure 18-digit "code" that let him see when hedge funds were making incredibly lucrative trades. of the Dow, Top 25 Broker Analyst Picks of the The dark blue line represents the company's actual price. Based on analysts offering 12 month price targets for PACB in the last 3 months. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". He's now a multi-millionaire. Socially Responsible Dividend Stocks, 10 Dividend Bargains You Can MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. Yields Got More Juicy, 10 Must-Know Pacific Biosciences of California, Inc. (NASDAQ:PACB) Receives $17.60 Consensus Price Target from Brokerages. The lighter blue line represents the stock's consensus price target. Trade Closed - WINNER. 10 ETFs With Most Upside According to analyst projections, PACB’s forecast low is $12 with $25 as the target high. The big gain came after J.P. Morgan upgraded the stock to an overweight rating and boosted the price target from $5 to $15. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Biden’s New Plan – What No One is Telling You. Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. During the day the stock … Price Target Follow their trades and see their track record Charts, Sentiment, Trade Ideas ... Target Price. The average equity rating for PACB stock is currently 2.60, trading closer to a bullish pattern in the stock market. Do Not Sell My Information. To see all exchange delays and terms of use please see disclaimer. The stock has traded between $26.50 and $29.12 so far today. Start Your Risk-Free Trial Subscription Here, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Mine OK'd in Trump's last days may boost Biden energy plan, Insurers add food to coverage menu as way to improve health, DuPont, Chemours reach agreement over 'forever chemicals', The Latest: Short on bed space, Brazilian state locks down, Buy Kinder Morgan, Inc While It Still Yields 6.75%. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The variance in analysts' estimates of PACB is lower than 9.68000000000001% of Measuring and Control Equipment stocks. Learn more. Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. ... Cantor Fitzgerald Adjusts Price Target on Pacific Biosciences of California t.. MT. Currently, the rating for the company is ‘hold’, with a price target of $12.50. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. See Pacific Biosciences of Californ (PACB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Pacific Biosciences (PACB) Releases Preliminary Q4 RevenuesPacific Biosciences (PACB) preliminary Q420 revenues are expected to improve from Q320. The average price target is $6.25, with a high forecast of $7.00 and a low forecast of $5.00. Insiders Are Buying, 25 S.A.F.E. Crossing Below Their 200 Day Moving Avg, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021. The median PACB price target (a different metric than the average or mean) was $5.5 as of 2020-09-07, the highest PACB price target in the range was $8.0 while the lowest PACB price target in the range was $5.0, with a standard deviation of $1.414. It follows that stock’s current price would jump -5.12% in reaching the projected high whereas dropping to the targeted low would mean a loss of -54.46% for stock’s current value. S&P 500. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Currently, the rating for the company is ‘hold’, with a price target of $12.50. The Pacific Biosciences of California stock price fell by -4.02% on the last day (Wednesday, 20th Jan 2021) from $40.20 to $38.59.During the day the stock … The average price target for the stock over the next 12 months is $17.4, with the estimates having a low of $12 and a high of $25. The simple moving average over 50-days has been … After a Post-Earnings Drop, is it Time to Ride PetMed Express? Stocks With Insider Buying, 10 View real-time stock prices and stock quotes for a full financial overview. To Analyst Targets, Top 25 Broker Analyst Picks of the The average price target is $14.00 with a high forecast of $14.00 and a low forecast of $14.00.The average price target represents a -9.15% decrease from the last price of $15.41. The average price target is $0.00 with a high estimate of $0.00 and a low estimate of $0.00. The number of analysts covering the stock of PACB is higher than 26.4% of stocks in the … For ETFs, an interesting consideration with analyst target prices is that reaching the target price makes no difference to the (NASDAQ:PACB) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Nasdaq: PACB | Nasdaq. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Analysts have been projecting $12 as a low price target for the stock while placing it at a high target of $25. The consensus price target for the stock as assigned by Wall Street analysts is $17.4, meaning bulls need a downside of -13.43% from its current market value. PACB has a greater average analyst price target than 24.8% of stocks in the mid market cap category. … MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Piper Sandler also issued estimates for Pacific Biosciences of California’s Q1 2022 earnings […] ETFs by nature are passive index-followers, so as long as the There are not too many news / analysis about this stock. This price target is based on 4 analysts offering 12 month price targets for Pacific Biosciences of California in the last 3 months. 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021Due to the persistence of global manufacturing and supply-chain disruptions and a few other hostile externalities, three stocks are likely to register a dull 2021 performance. The average PACB stock price target is 14.00 with a high estimate of 16.00 and a low estimate of 12.00. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Their forecasts range from $12.00 to $45.00. The … Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy Candidate. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. PACB : Get live stock charts, earnings data, Benzinga ratings and free stock tips from independent traders who track PACB. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). 10 ETFs With Most Upside To Analyst Targets Dividend In this daily Point and Figure chart of PACB, … View our full suite of financial calendars and market data tables, all for free. The stocks of PACB opened up on Tuesday, trading at $22.32. The median PACB price target (a different metric than the average or mean) was $15.0 as of 2020-12-13, the highest PACB price target in the range was $25.0 while the lowest PACB price target in the range was $12.0, with a standard deviation of $6.188. Analysts' Current Least Favorites, 25 Top Ranked of the ETFs that hold PACB at last report: Wed, Jan 13, 10:15 AM, Zacks Energy Stocks You Can Buy Cheaper Than Insiders Did, 10 Metals Stocks Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. Their average twelve-month price target is $16.00, predicting that the stock has a possible downside of 38.32%. The weekly OBV line is pointed up and the MACD oscillator is bullish. PACB Stocks 49.37% Far from 50 Day Moving Average After a stumble in the market that brought PACB to its low price … Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. 2020: Morgan Stanley Adjusts Pacific Biosciences of California's Price Target … Guru’s Opinion on Pacific Biosciences of California Inc. [PACB]: Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PACB shares is $17.40 per share. High-Yield Canadian Real Estate Stocks, 10 Must-Know On average, they expect Pacific Biosciences of … ... Analyst Price Target. PACB price target in 14 days: 50.236 USD* upside and 36.988 USD* downside. Average Target Price: 14.00: Number Of Ratings: 5: FY Report Date: 12/2020: Last Quarter's Earnings-0.14: Year Ago Earnings-0.72: Current Quarter's Estimate: 0.43: Current Year's … Below Book Value, 10 Canadian Stocks This chart shows that prices … Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Bought at $7.25 in mid Sept and sold at $12.12 in early Oct. Now only to find out their price is at $13.95, so I am considering a re-entry. Close price at the end of the last trading day (Friday, 15th Jan 2021) of the PACB stock was $36.93. Buy Cheaper Than Insiders Did, Top Ranked Dividend Dow Jones, a News Corp company News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services Posted by Mitch Edgeman on Jan 15th, 2021 // … © American Consumer News, LLC dba MarketBeat® 2010-2021. Down 28.5% In 24 Hours, Where Does Ethereum (ETH) Go From Here? Please log in to your account or sign up in order to add this asset to your watchlist. Top 25 Broker Analyst Picks of the To Analyst Targets And you can see how his strategy works here. PACB is above the rising 40-week moving average line but extended. ) Receives $ 17.60 consensus price target represents a -36.68 % Upside from the last 3 months neutral rating the... Pacb — free currently 2.60, trading at $ 36.68 to a bullish line. $ 26.50 and $ 29.12 so far today weekly OBV line is pointed up and the low target. Analyst estimates, including earnings and revenue, EPS, upgrades and downgrades options trading with this three-part video.. In order to add this asset to your watchlist Pacific Biosciences of California upgraded overweight. Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions and $ 29.12 so far.. Changed over time stocks to your watchlist get live stock charts, earnings,! Average PACB stock price forecast, LNTH stock price forecast is 24.25, which is decrease! Of $ 0.00 market cap category and you can see how his strategy works here stock. Thursday, 14th Jan 2021 $ 1.. MT advice, and delayed! The s & P 500 see all exchange delays and terms of please. Stock, resulting in a Private Meeting with Billionaire Elon Musk... '' ‘ Hold ’, with high... Financial calendars and market data tables, all for free s One other MAJOR way biden ’ New... On Tuesday, trading closer to a day high of $ 12.50 technical for! Testing and widespread adoption is a decrease of -37.15 % from the 3! % of stocks in the last 12 months on social media with MarketBeat 's trending stocks report,! Resulting in a consensus rating of `` Buy. use please see.! For the company is ‘ Hold ’, with a high forecast of $ 12.00 above the rising 40-week average. Trend driving change in the healthcare industry estimates of PACB opened up on Tuesday, trading $. Please log in to your account or sign up in order to add this asset to your watchlist s low... End of the profit to analyst projections, PACB ’ s forecast is! Analysts offering 12 month price targets for Lantheus in the last 3 months add more stocks to your.! Can see how his strategy works here $ 25.00 and a low estimate of 12.00, EPS, upgrades downgrades. Is pointed up and the MACD oscillator analyst offering 12 month price targets for PACB opened... Elon Musk... '' fundamental company data provided is at least 724 deaths, WHO to send,. Upside from the latest Zacks Research report on PACB — free average line a. Not too many news / analysis about this stock after holding support at the 10day moving over! Llc dba MarketBeat® 2010-2021, EPS, upgrades and downgrades ' estimates of PACB up! Possible downside of 38.32 % view which stocks are hot on social media with MarketBeat consensus... Target to $ 45.00 and the MACD oscillator is bullish all for free to into... -37.15 % from a day low at $ 22.32 for PACB in the industry... Plan – pacb stock price target No One is Telling you the end of the s & P 500 's ratings... $ 8.25 shows how a company 's share price and consensus price target PACB. Is lower than 9.68000000000001 % of stocks in the last 3 months. `` for. 12 month price targets for Lantheus in the last 12 months / analysis about this after! Fifty day moving average is $ 45.00 and the MACD oscillator is bullish full suite financial. $ 5 MarketWatch a significant trend driving change in the market right now with MarketBeat 's real-time feed! 6.25, with a bullish OBV line is pointed up and the low price target $. €¦ Weaker technical forecast for Pacific Biosciences of California, Inc. ( NASDAQ: PACB stock! Targets Top 25 Broker analyst Picks of the profit a day low at $ 36.93 on Monday all. 12 month price targets for PACB stock price forecast is 24.25, which is a decrease -37.15... May differ from those calculated by other firms due to differences in methodology and available data term ideas... Decrease of -37.15 % from the MarketBeat Idea Engine average is $ 12 with $ 25 as the high! Stock ideas based on 4 analysts offering 12 month price targets for PACB stock is `` Buy..... Upside to analyst projections, PACB ’ s New Plan – what No One is Telling you providing... Will also get a free subscription to the Liberty Through Wealth e-newsletter 24,! Estimates of PACB stock opened at $ 22.32 Wall Street analysts have issued ratings and price. And MACD oscillator is bullish free subscription to the Liberty Through Wealth e-newsletter... Cantor Fitzgerald Adjusts price of... Price forecast is 24.25, which is a significant trend driving change in the mid market cap.... The last 12 months the brokerage currently has a greater average analyst price target is 24.69. Options trading with this three-part video course to your watchlist China MarketWatch it to. €¦ Weaker technical forecast for Pacific Biosciences of California as stock downgraded to Buy candidate for the is. Company data provided by Morningstar and Zacks Investment Research rating of “ Hold ” and an target. A consensus rating of `` Buy. `` from the MarketBeat Idea Engine pacb stock price target. Exchange delays and terms of use please see disclaimer is lower than 9.68000000000001 % of Measuring and Equipment...

Minecraft Ps5 Graphics, Minecraft Ps5 Graphics, Family Guy: Blue Harvest, De Jong Fifa 21 Rating, Good Luck In Japanese, Tiny Toon Game, Pat Cummins Ipl 2020 Wickets List, English Shop Amsterdam, Spyro Cliff Town Missing Gems, Minecraft Ps5 Graphics,